Patterns of cardiac dysfunction after carbon monoxide poisoning.


Journal

Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc
ISSN: 1066-2936
Titre abrégé: Undersea Hyperb Med
Pays: United States
ID NLM: 9312954

Informations de publication

Date de publication:
Historique:
entrez: 15 9 2020
pubmed: 16 9 2020
medline: 5 1 2021
Statut: ppublish

Résumé

To describe the structural sequelae of carbon monoxide (CO) poisoning on the heart assessed using stress cardiac MRI (CMR). CO poisoning is common. While acute cardiac injury is frequent among survivors, the mid- and long-term effects of CO on the myocardium are unclear. CMR studies performed between the years 2005 and 2014 for a primary diagnosis of CO poisoning at a tertiary care center were reviewed by an experienced cardiologist. Variables of interest were compared between patients with normal and abnormal studies to identify factors associated with cardiac dysfunction. Eighty-eight patients underwent stress CMR, age 34 years (range 11-70); 49% were male, 74 had acute poisoning and 14 had chronic poisoning (CO exposure for longer than 24 hours). Time from CO poisoning to imaging was 24 months (1 day-120 months). Patients were stratified into four categories, which included those with acute poisoning imaged: ≤12 months; 12-60 months; >60 months from the event; and those with chronic poisoning. Overall, 26 studies (30%) were abnormal. The most common findings were: left ventricular systolic dysfunction in 14 patients, right ventricular systolic dysfunction in nine, and LV dilatation in six. Abnormalities were mild in most cases and were equally prevalent in all four patient categories. Dyspnea at the time of follow-up was more frequent among those with abnormal studies. Mild alterations in ventricular structure and function are frequent in survivors of CO poisoning. Myocardial scarring is rare, suggesting that acute hypoxic injury may not fully explain these abnormalities.

Identifiants

pubmed: 32931676
doi:

Substances chimiques

Troponin I 0
Carboxyhemoglobin 9061-29-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

477-485

Informations de copyright

Copyright© Undersea and Hyperbaric Medical Society.

Déclaration de conflit d'intérêts

The authors of this paper declare no conflicts of interest exist with this submission.

Auteurs

Miguel Alvarez Villela (M)

Hyperbaric Medicine Division, Intermountain Medical Center, Murray, Utah U.S.
Division of Cardiovascular Medicine, University of Utah School of Medicine, Salt Lake City, Utah.

Omar Wever-Pinzon (O)

Division of Cardiovascular Medicine, University of Utah School of Medicine, Salt Lake City, Utah.

Mona Parikh (M)

Hyperbaric Medicine Division, Intermountain Medical Center, Murray, Utah U.S.

Kayla Deru (K)

Hyperbaric Medicine Division, Intermountain Medical Center, Murray, Utah U.S.

Joseph B Muhlestein (JB)

Intermountain Heart Institute, Intermountain Medical Center, Murray, Utah.
University of Utah School of Medicine, Salt Lake City, Utah.

Jeffrey L Anderson (JL)

Intermountain Heart Institute, Intermountain Medical Center, Murray, Utah.
University of Utah School of Medicine, Salt Lake City, Utah.

Lindell K Weaver (LK)

Hyperbaric Medicine Division, Intermountain Medical Center, Murray, Utah U.S.
University of Utah School of Medicine, Salt Lake City, Utah.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH